Japanese Bridging Study of Ivosidenib (AG-120) in Healthy Subjects
Clinical trial NCT03071770 · COMPLETED
Trial details
- NCT number
- NCT03071770
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-31
- Primary completion
- 2017-05-09
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.